Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations.
Szpurka
Hadrian
H
Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Jankowska
Anna M
AM
Makishima
Hideki
H
Bodo
Juraj
J
Bejanyan
Nelli
N
Hsi
Eric D
ED
Sekeres
Mikkael A
MA
Maciejewski
Jaroslaw P
JP